Skip to content

Effect of Vojta Therapy on Covid-19 Respiratory Disease

Effect of Vojta Therapy in Respiratory Disease Caused by SARS-CoV-2. Randomized Controlled Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05031858
Enrollment
40
Registered
2021-09-02
Start date
2021-09-25
Completion date
2022-04-15
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Keywords

Vojta therapy, Respiratory physiotherapy

Brief summary

Vojta therapy is a physiotherapy intervention with scientific evidence in respiratory pathologies in children and proven in adults. In this pilot study with an RCT design, its effect in adult patients with respiratory pathology caused by the SARS-CoV-2 virus will be studied. The non-invasive and non-painful technique consists of applying tolerable pressure to specific areas of the patient's body. The objective is to activate, in a reflex way, the ventilatory physiology. It is compared with the conventional respiratory physiotherapy approach.

Interventions

Respiratory physiotherapy

Sponsors

Hospital de Emergencias Enfermera Isabel Zendal de Madrid
CollaboratorUNKNOWN
NUMEN Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* respiratory disease by covid-19

Exclusion criteria

* patient older than 75 years

Design outcomes

Primary

MeasureTime frameDescription
SpO23 weeksOxygen saturation
Breathing frequency3 weeksfrequency of respiratory cycles per minute
Stay time3 weeksDays of stay in the intermediate respiratory care unit

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026